Factors Affecting Quality Control (QC) Failure Rates in Somatic Breast Cancer (BRCA) Gene Testing in Castrate
Cian O'Leary1, Edward Yoong1, Admire Matsika2
1Mater Cancer Care Centre, Mater Hospital Brisbane, Brisbane, Queensland, Australia.
Somatic BRCA testing in castrate-resistant prostate cancer (CRPC) can fail due to older tissue samples. A longer time from biopsy to testing increases inconclusive results, suggesting repeat biopsies for samples over 5 years old.
Area of Science:
- Oncology
- Genetics
- Cancer Diagnostics
Background:
- Castrate-resistant prostate cancer (CRPC) has poor prognostic outcomes.
- Mutations in Breast cancer (BRCA) genes 1 and 2 are associated with poorer prognoses in prostate cancer.
- Somatic BRCA testing is crucial for targeted therapy but can yield inconclusive results, hindering patient access.
Purpose of the Study:
- To assess somatic BRCA testing results in a cohort of CRPC patients.
- To identify factors contributing to quality control (QC) failures and inconclusive testing.
Main Methods:
- Retrospective review of CRPC patient records from 2020-2023.
- Identification of patients with somatic BRCA testing.
- Collection of data on biopsy characteristics, time to result, and test outcomes.
Main Results:
- Out of 147 CRPC patients, 54 (40%) underwent somatic BRCA testing.
- 35 tests (65%) yielded actionable results; 19 (35%) were inconclusive/QC failures.
- QC failures significantly correlated with longer intervals from biopsy to testing (60 vs. 27 months, p=0.033).
Conclusions:
- Extended tissue retention intervals before somatic BRCA testing increase the risk of inconclusive results.
- Repeat biopsy for BRCA testing is recommended for CRPC patients with archival tissue older than 5 years.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
Related Concept Videos
Cancer Survival Analysis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
